Gastrointestinal Drugs Market Growth Sturdy at 4.9% CAGR to Outstrip $71,300.28 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
10 mai 2021 09h30 HE
|
The Insight Partners
Pune, India., May 10, 2021 (GLOBE NEWSWIRE) -- Gastrointestinal Drugs Market: Key InsightsAccording to our new research study on “Gastrointestinal Drugs Market to 2027 – Global Analysis and Forecast...
Provation and Iterative Scopes Announce Exclusive AI Partnership
17 mars 2021 12h41 HE
|
Provation
Minneapolis, MN and Cambridge, MA, March 17, 2021 (GLOBE NEWSWIRE) -- Provation and Iterative Scopes announced today an exclusive partnership, bringing together the premier clinical productivity and...
Microsurgery Robot Market Trends 2021 | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
25 févr. 2021 05h00 HE
|
Graphical Research
Pune, India, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The microsurgery robot market demand is expected to witness an uptick throughout the world as robotic surgeries allow surgeons to perform numerous...
Aspero Medical completes animal clinical study and announces the formation of Clinical Advisory Board
29 déc. 2020 10h24 HE
|
Innosphere Ventures
Boulder, Colorado, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup focused on developing new products for the field of gastroenterology recently completed the company’s...
Human Microbiome Modulators Market Size To Be Worth USD 5.24 Billion by 2027 Growing at a CAGR of 16.5% | Emergen Research
22 déc. 2020 08h33 HE
|
Emergen Research
Vancouver, British Columbia, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The Global Human Microbiome Modulators Market is forecast to be worth USD 5.24 Billion by 2027, according to the current analysis by...
Aspero Medical receives $225,000 Grant for development of intraoperative gastrointestinal endoscopic balloon overtube
18 août 2020 11h27 HE
|
Innosphere
Boulder, Colorado, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup focused on developing solutions and applications for the field of gastroenterology, has received a...
The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy (“DGT”) clinical trial
29 juin 2020 21h39 HE
|
Biomerica, Inc.
InFoods® Diagnostic-Guided Therapy is designed to identify patient-specific foods that, when removed from the diet, may alleviate an individual's IBS symptoms Approximately 45 million Americans...
Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each of the Merger Proposals
06 mai 2020 09h15 HE
|
Ritter Pharmaceuticals, Inc.
LOS ANGELES, May 06, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that Institutional Shareholder Services Inc....
Ritter Pharmaceuticals, Inc. Urges Stockholders to Vote Now on Proposed Merger with Biotech Company, Qualigen Inc.
28 avr. 2020 07h30 HE
|
Ritter Pharmaceuticals, Inc.
The merger CANNOT be consummated without the approval of EACH of the proposals being voted on at the Special Meeting, including approval of a reverse stock split. LOS ANGELES, April 28, 2020 ...
Aspero Medical announces James Willett as CEO
19 sept. 2019 17h26 HE
|
Innosphere
Boulder, Colorado, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Aspero Medical, University of Colorado Boulder spinoff and Innosphere client company, announced today that James Willett has been appointed...